Practical aspects of management of recurrent aphthous stomatitis.

The treatment of chronic recurrent oral aphthous ulcers. Dtsch Arztebl Int (2014) 1.86

Mucosal microbiome in patients with recurrent aphthous stomatitis. J Dent Res (2014) 0.86

The efficacy of a paste containing Myrtus communis (Myrtle) in the management of recurrent aphthous stomatitis: a randomized controlled trial. Clin Oral Investig (2009) 0.85

Recurrent aphthous stomatitis. Dent Clin North Am (2014) 0.85

Repurposing of yunnan baiyao as an alternative therapy for minor recurrent aphthous stomatitis. Evid Based Complement Alternat Med (2012) 0.82

Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis: A Randomized Controlled Trial. J Dent (Tehran) (2014) 0.79

Efficacy of rebamipide and levamisole in the treatment of patients with recurrent aphthous ulcer - a comparative study. J Clin Diagn Res (2014) 0.78

Is Optimal Management of Recurrent Aphthous Stomatitis Possible? A Reality Check. J Clin Diagn Res (2016) 0.75

A double blind, randomised placebo controlled trial of topical 2% viscous lidocaine in improving oral intake in children with painful infectious mouth conditions. BMC Pediatr (2011) 0.75

Efficacy of sucralfate for the treatment of post-tonsillectomy symptoms. Eur Arch Otorhinolaryngol (2014) 0.75

Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol (2000) 2.42

A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol (2006) 1.78

What is the pathogenesis of acne? Exp Dermatol (2005) 1.40

European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40

Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Br J Dermatol (2014) 1.39

[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38

Current use and future potential role of retinoids in dermatology. Drugs (1997) 1.35

13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21

Generalized lichen nitidus. J Am Acad Dermatol (1997) 1.19

Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci (2007) 1.18

Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18

Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol (1995) 1.16

Vitamins as hormones. Horm Metab Res (2007) 1.14

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol (2012) 1.06

Endoscopic diagnosis of gastric varices. Endoscopy (1994) 1.06

Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05

Current concepts in the treatment of recurrent aphthous stomatitis. Skin Therapy Lett (2008) 1.04

Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02

Remobilization of leaf S compounds and senescence in response to restricted sulphate supply during the vegetative stage of oilseed rape are affected by mineral N availability. J Exp Bot (2009) 1.00

Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res (1999) 0.99

Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol (2013) 0.99

An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol (2012) 0.98

Diabetes mellitus and the risk of cancer. Minerva Endocrinol (2011) 0.97

Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol (2008) 0.96

Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol (2007) 0.96

[Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data]. Ophthalmologe (2012) 0.93

Cellular stress causes reversible, PRKAA1/2-, and proteasome-dependent ID2 protein loss in trophoblast stem cells. Reproduction (2010) 0.93

Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol (1992) 0.93

What causes hidradenitis suppurativa? Exp Dermatol (2008) 0.92

Is acne vulgaris a genuine inflammatory disease? Dermatology (2001) 0.90

Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol (2009) 0.90

Twenty-eight cases of juvenile-onset Adamantiades-Behçet disease in Germany. Dermatology (1999) 0.90

Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res (2007) 0.89

[Behçet's disease in Tunisia. Clinical study of 519 cases]. Rev Med Interne (2006) 0.89

Superimposed primary chancre in a patient with Adamantiades-Behçet's disease. Sex Transm Infect (1999) 0.89

Pathogenesis and pathogenesis related treatment of acne. J Dermatol (1991) 0.88

A retinoic acid-inducible skin-specific gene (RIS-1/psoriasin): molecular cloning and analysis of gene expression in human skin in vivo and cultured skin cells in vitro. Mol Biol Rep (1994) 0.88

Oral retinoids in the treatment of seborrhoea and acne. Dermatology (1998) 0.88

[Interferon-alpha-induced psoriasis vulgaris]. Hautarzt (1996) 0.87

Effect of 5alpha-dihydrotestosterone and testosterone on apoptosis in human dermal papilla cells. Skin Pharmacol Physiol (2006) 0.87

The 5 alpha-reductase system and its inhibitors. Recent development and its perspective in treating androgen-dependent skin disorders. Dermatology (1996) 0.87

Effect of skin surface temperature on skin pigmentation during contact and intralesional cryosurgery of keloids. J Eur Acad Dermatol Venereol (2007) 0.86

Influence of physiological androgen levels on wound healing and immune status in men. Aging Male (2006) 0.86

Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study. Dermatology (2000) 0.86

Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis. Br J Dermatol (2014) 0.85

Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85

Nuclear hormone receptors in human skin. Horm Metab Res (2007) 0.85

Acne-associated syndromes: models for better understanding of acne pathogenesis. J Eur Acad Dermatol Venereol (2010) 0.85

[Takayasu's arteritis associated with acute myeloblastic leukemia]. J Mal Vasc (2006) 0.85

A novel tetracycline-controlled transactivator-transrepressor system enables external control of oncolytic adenovirus replication. Gene Ther (2003) 0.85

Merkel cell carcinoma: report of ten cases with emphasis on clinical course, treatment, and in vitro drug sensitivity. J Am Acad Dermatol (1997) 0.84

Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84

Increased expression of tenascin C by keloids in vivo and in vitro. Br J Dermatol (1999) 0.83

Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells--evidence of its presence in melanocytes. J Invest Dermatol (1998) 0.83

Keratosis pilaris/ulerythema ophryogenes and 18p deletion: is it possible that the LAMA1 gene is involved? J Med Genet (2001) 0.83

Recalcitrant severe erosive cutaneous lichen planus treated with extracorporeal photopheresis monotherapy. Br J Dermatol (2011) 0.83

All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. Horm Metab Res (2007) 0.83

[Olfactory dysfunction. Epidemiology, pathophsiological classification, diagnosis and therapy]. HNO (2004) 0.82

Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. Clin Exp Rheumatol (2006) 0.82

Clinical, biochemical, and experimental studies on lactation. V. Clinical effects of steroids on the initiation of lactation. Am J Obstet Gynecol (1970) 0.81

Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology (2001) 0.81

Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate. Dermatology (2000) 0.81

[Eosinophilic fasciitis (Shulman's disease): a case series of 11 patients]. Rev Med Interne (2010) 0.81

Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology (1998) 0.81

The SAHA syndrome. Horm Res (2000) 0.81

Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. Expert Opin Pharmacother (2008) 0.81

Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro. J Invest Dermatol (1993) 0.81

Skin physiology and textiles - consideration of basic interactions. Curr Probl Dermatol (2006) 0.80

Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons? Neuroscience (1994) 0.80

Remission of scleromyxoedema following treatment with extracorporeal photopheresis. Br J Dermatol (1996) 0.80

Inhibition of the androgen receptor by antisense oligonucleotides regulates the biological activity of androgens in SZ95 sebocytes. Horm Metab Res (2007) 0.80

Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne. J Eur Acad Dermatol Venereol (2006) 0.80

Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease. Eye (Lond) (2008) 0.80

Hormonal changes in cerebral infarction in the young and elderly. J Neurol Sci (1990) 0.79

Sebaceous cells in monolayer culture. In Vitro Cell Dev Biol (1993) 0.79

Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation? Dermatology (2011) 0.79

Epidermodysplasia verruciformis associated with neurofibromatosis type 1: coincidental association or model for understanding the underlying mechanism of the disease? Br J Dermatol (2002) 0.79

Corticotropin releasing hormone and its function in the skin. Horm Metab Res (2007) 0.79

[Epidemiology of ocular involvement in Adamantiades-Behçets disease]. Ophthalmologe (2012) 0.78

IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. Clin Exp Rheumatol (2008) 0.78

Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro. Horm Metab Res (2007) 0.78

Biological effects and metabolism of 9-cis-retinoic acid and its metabolite 9,13-di-cis-retinoic acid in HaCaT keratinocytes in vitro: comparison with all-trans-retinoic acid. Arch Dermatol Res (2000) 0.78

Reduced growth of beard as the only diagnostic sign in a patient with macroprolactinoma. J Eur Acad Dermatol Venereol (2007) 0.78

Side-effects of topical androgenic and anabolic substances and steroids. A short review. Acta Dermatovenerol Alp Pannonica Adriat (2007) 0.78

Human sebocytes express prostaglandin E2 receptors EP2 and EP4 but treatment with prostaglandin E2 does not affect testosterone production. Br J Dermatol (2009) 0.78

Peroxisome proliferator-activated receptor activators protect sebocytes from apoptosis: a new treatment modality for acne? Br J Dermatol (2010) 0.78

Endocrinology of the skin--a promising joint adventure. Horm Metab Res (2007) 0.78

Intestinal vasculitis in Adamantiades-Behçet disease presenting as acute abdomen. J Eur Acad Dermatol Venereol (2009) 0.77

[Juvenile Adamantiades-Behçet disease in decreased stimulation with anti-CD3 monoclonal antibody]. Hautarzt (1997) 0.77

Early descriptions of Adamantiades-Behçet's disease. Ann Rheum Dis (2003) 0.77

[Skin diseases in geriatric patients. Epidemiologic data]. Hautarzt (2012) 0.76

Steroid contraceptives: neuro-psychiatric & electroencephalographic complications. J Int Med Res (1973) 0.76

Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Behçet disease. Arch Dermatol (1996) 0.76

Is nerve growth factor a serum marker for neurological and psychiatric complications in Behcet's disease? Lancet (1996) 0.76

Development of efficient transient transfection systems for introducing antisense oligonucleotides into human epithelial skin cells. Horm Res (2000) 0.76

[Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome]. Dtsch Med Wochenschr (1998) 0.76

[Dermatoendocrinology. Skin aging]. Hautarzt (2010) 0.76

Heterogeneity and quantitative differences of type 1 5 alpha-reductase expression in cultured skin epithelial cells. Dermatology (1998) 0.76

Distant cutaneous manifestation of Crohn's disease presenting as a granulomatous erysipelas-like lesion. J Eur Acad Dermatol Venereol (1999) 0.76